中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
20期
146-146,147
,共2页
肾盂肾炎%头孢哌酮-舒巴坦
腎盂腎炎%頭孢哌酮-舒巴坦
신우신염%두포고동-서파탄
Pyelonephritis%Sulbactam and Cefopcrazone,Cefperazone-Sulbactam
目的：观察头孢哌酮-舒巴坦治疗肾盂肾炎的临床疗效。方法：将笔者所在医院收治的48例肾盂肾炎患者随机分为两组：对照组应用左氧氟沙星治疗，治疗组应用头孢哌酮-舒巴坦治疗，对比两组患者的治疗效果、不良反应情况。结果：治疗1个疗程后，治疗组的总有效率显著高于对照组(P<0.05)；治疗组在治疗后6个月内的复发率明显低于对照组(P<0.05)。两组不良反应比较差异无统计学意义(P>0.05)。结论：对肾盂肾炎患者应用头孢哌酮-舒巴坦治疗，具有显著疗效，且安全性好，是治疗肾盂肾炎的理想药物。
目的：觀察頭孢哌酮-舒巴坦治療腎盂腎炎的臨床療效。方法：將筆者所在醫院收治的48例腎盂腎炎患者隨機分為兩組：對照組應用左氧氟沙星治療，治療組應用頭孢哌酮-舒巴坦治療，對比兩組患者的治療效果、不良反應情況。結果：治療1箇療程後，治療組的總有效率顯著高于對照組(P<0.05)；治療組在治療後6箇月內的複髮率明顯低于對照組(P<0.05)。兩組不良反應比較差異無統計學意義(P>0.05)。結論：對腎盂腎炎患者應用頭孢哌酮-舒巴坦治療，具有顯著療效，且安全性好，是治療腎盂腎炎的理想藥物。
목적：관찰두포고동-서파탄치료신우신염적림상료효。방법：장필자소재의원수치적48례신우신염환자수궤분위량조：대조조응용좌양불사성치료，치료조응용두포고동-서파탄치료，대비량조환자적치료효과、불량반응정황。결과：치료1개료정후，치료조적총유효솔현저고우대조조(P<0.05)；치료조재치료후6개월내적복발솔명현저우대조조(P<0.05)。량조불량반응비교차이무통계학의의(P>0.05)。결론：대신우신염환자응용두포고동-서파탄치료，구유현저료효，차안전성호，시치료신우신염적이상약물。
Objective:To observe the clinical efficacy of Sulbactam and Cefopcrazone,Cefperazone-Sulbactam in the treatment of pyelonephritis. Method:48 cases of pyelonephritis patients in our hospital were randomly divided into two groups,control group was treated with Levofloxacin,the treatment group were treated with Sulbactam and Cefopcrazone,Cefperazone-Sulbactam,the treatment effect and the adverse reaction in two groups were compared.Result:After one course of treatment,the total efficiency of the treatment group was significantly higher than that in the control group(P<0.05),the recurrence rate of the treatment group in 6 months was lower than that in the control group(P<0.05),the adverse reaction in two groups had no significantly difference(P>0.05).Conclusion:Sulbactam and Cefopcrazone,Cefperazone-Sulbactam in the treatment of pyelonephritis is significant efficacy,and safety,and is an ideal drug treatment of pyelonephritis.
